These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7648764)
41. An S-mephenytoin cysteine conjugate identified in urine of extensive but not of poor metabolizers of S-mephenytoin. Tybring G; Nordin J; Bergman T; Bertilsson L Pharmacogenetics; 1997 Oct; 7(5):355-60. PubMed ID: 9352570 [TBL] [Abstract][Full Text] [Related]
42. Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicin. Zhou HH; Anthony LB; Wood AJ; Wilkinson GR Br J Clin Pharmacol; 1990 Sep; 30(3):471-5. PubMed ID: 2223426 [TBL] [Abstract][Full Text] [Related]
43. The elimination of diazepam in Chinese subjects is dependent on the mephenytoin oxidation phenotype. Wan J; Xia H; He N; Lu YQ; Zhou HH Br J Clin Pharmacol; 1996 Oct; 42(4):471-4. PubMed ID: 8904619 [TBL] [Abstract][Full Text] [Related]
44. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin. Bertilsson L; Lou YQ; Du YL; Liu Y; Kuang TY; Liao XM; Wang KY; Reviriego J; Iselius L; Sjöqvist F Clin Pharmacol Ther; 1992 Apr; 51(4):388-97. PubMed ID: 1345344 [TBL] [Abstract][Full Text] [Related]
45. Enantioselective high-performance liquid chromatographic assay for determination of the enantiomers of a new anti-ulcer agent, E3810, in beagle dog plasma and rat plasma. Takakuwa S; Chiku S; Nakata H; Yuzuriha T; Mano N; Asakawa N J Chromatogr B Biomed Appl; 1995 Nov; 673(1):113-22. PubMed ID: 8925064 [TBL] [Abstract][Full Text] [Related]
46. Interethnic difference in omeprazole's inhibition of diazepam metabolism. Caraco Y; Tateishi T; Wood AJ Clin Pharmacol Ther; 1995 Jul; 58(1):62-72. PubMed ID: 7628184 [TBL] [Abstract][Full Text] [Related]
47. Simultaneous measurement of proguanil and its metabolites in human plasma and urine by reversed-phase high-performance liquid chromatography, and its preliminary application in relation to genetically determined S-mephenytoin 4'-hydroxylation status. Kusaka M; Setiabudy R; Chiba K; Ishizaki T Am J Trop Med Hyg; 1996 Feb; 54(2):189-96. PubMed ID: 8619446 [TBL] [Abstract][Full Text] [Related]
48. Effect of clopidogrel on the hydroxylation and sulfoxidation of omeprazole: A single dose study in healthy human volunteers. Ahmad L; Iqbal Z; Nazir S; Khan A; Shah Y; Khan MI; Khan I; Khan A EXCLI J; 2017; 16():321-327. PubMed ID: 28507476 [TBL] [Abstract][Full Text] [Related]
49. Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients. Denisenko NP; Sychev DA; Sizova ZM; Smirnov VV; Ryzhikova KA; Sozaeva ZA; Grishina EA Pharmgenomics Pers Med; 2017; 10():253-259. PubMed ID: 29033601 [TBL] [Abstract][Full Text] [Related]
50. Stereoselectivity of the arene epoxide pathway of mephenytoin hydroxylation in man. Küpfer A; Lawson J; Branch RA Epilepsia; 1984 Feb; 25(1):1-7. PubMed ID: 6420144 [TBL] [Abstract][Full Text] [Related]
51. Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole. Andersson T; Cederberg C; Edvardsson G; Heggelund A; Lundborg P Clin Pharmacol Ther; 1990 Jan; 47(1):79-85. PubMed ID: 2104790 [TBL] [Abstract][Full Text] [Related]
52. Plasma direct injection high-performance liquid chromatographic method for simultaneously determining E3810 enantiomers and their metabolites by using flavoprotein-conjugated column. Mano N; Oda Y; Takakuwa S; Chiku S; Nakata H; Asakawa N J Pharm Sci; 1996 Sep; 85(9):903-7. PubMed ID: 8877876 [TBL] [Abstract][Full Text] [Related]
53. Interaction between Omeprazole and Gliclazide in Relation to CYP2C19 Phenotype. Dujic T; Cvijic S; Elezovic A; Bego T; Imamovic Kadric S; Malenica M; Elezovic A; Pearson ER; Kulo A J Pers Med; 2021 May; 11(5):. PubMed ID: 34063566 [TBL] [Abstract][Full Text] [Related]
54. No influence of single intravenous doses of omeprazole on theophylline elimination kinetics. Oosterhuis B; Jonkman JH; Andersson T; Zuiderwijk PB J Clin Pharmacol; 1992 May; 32(5):470-5. PubMed ID: 1587966 [TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics and metabolism of the proton pump inhibitor pantoprazole in man. Radhofer-Welte S Drugs Today (Barc); 1999 Oct; 35(10):765-72. PubMed ID: 12973371 [TBL] [Abstract][Full Text] [Related]
56. Influence of urinary pH on the disposition of methoxyphenamine and three metabolites in humans. Roy SD; Hawes EM; Midha KK J Pharm Sci; 1987 Jun; 76(6):427-32. PubMed ID: 3625484 [TBL] [Abstract][Full Text] [Related]
57. Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies. Zhang Y; Blouin RA; McNamara PJ; Steinmetz J; Wedlund PJ Br J Clin Pharmacol; 1991 Mar; 31(3):350-2. PubMed ID: 2054275 [TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers. Yasuda S; Ohnishi A; Ogawa T; Tomono Y; Hasegawa J; Nakai H; Shimamura Y; Morishita N Int J Clin Pharmacol Ther; 1994 Sep; 32(9):466-73. PubMed ID: 7820329 [TBL] [Abstract][Full Text] [Related]
59. The Effects of Vonoprazan Fumarate on the Tacrolimus Blood Concentration in Liver Transplant Recipients. Hidaka M; Soyama A; Hashizume J; Hara T; Matsunaga N; Matsushima H; Tanaka T; Hamada T; Imamura H; Adachi T; Kanetaka K; Ohyama K; Eguchi S Cancer Diagn Progn; 2022; 2(5):553-557. PubMed ID: 36060027 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of the relationship between polymorphisms in CYP2C19 and the single-dose pharmacokinetics of omeprazole in healthy Chinese volunteers: A multicenter study. Zhou S; Xie R; Zhang X; He X; Huang J; Jungang Y; Liao M; Ding Y; Yang D; Liu Y; Zhang Q; Yang G; Liu F; Guan S; He Q; Lou H; Gong F; Meng X; Xiang Q; Zhao X; Cui Y Clin Transl Sci; 2022 Jun; 15(6):1439-1448. PubMed ID: 35235711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]